Read More Pharma Industry News Can dual agonist drugs like amycretin and tirzepatide replace bariatric surgery by 2030? Can new obesity drugs like amycretin and tirzepatide replace bariatric surgery by 2030? Discover what clinical data and cost trends reveal about the future. byPallavi MadhirajuJune 27, 2025